doi: 10.1124/jpet.300.3.958 71 BassilFCanronM-HVitalABezardELiYGreigNHet al
Incorporating these pharmacological agents can appeal to patients who are ambivalent about surgery, potentially increasing the overall pool of individuals engaging with weight-loss treatment, while still maintaining surgical solutions for those who need or prefer them
Conventional anti-obesity medications are limited to short-term use and have adverse effects, which have contributed to the rise of GLP-1 RAs, e.g., liraglutide, semaglutide, dulaglutide
Prog Neurobiol (2011) 94:389407.10.1016/j.pneurobio.2011.06.005 86 MarsdenCD
Look for brands that utilize third-party testing to verify the potency of the product and ensure it is free from heavy metals, molds, and synthetic fillers